- $207.37m
- $208.33m
- $66.58m
Exagen Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Exagen, Others Collaborate To Develop Novel Patented Biomarkers Into Clinical Diagnostic Tests
U.S. STOCKS ON THE MOVE-ViacomCBS, Fly Leasing, Boeing, Coupang
Exagen to study autoimmune disease development in COVID-19 patients, shares rise
Brief: Exagen Inc Announces Study On The Long-Term Effects Of Covid-19 Infection
U.S. STOCKS ON THE MOVE-Baidu, Exagen, Hoth Therapeutics, Netflix
U.S. STOCKS ON THE MOVE-Baidu, Ionis Pharmaceuticals, ViacomCBS, Netflix
Exagen drops on $60 mln equity raise
Brief: Exagen Inc Announces Pricing Of Public Offering Of Common Stock
Brief: Exagen Announces Proposed Public Offering Of Common Stock
U.S. RESEARCH ROUNDUP- Comcast, Hershey, Oracle
Brief: Exagen Inc. Reports Fourth Quarter And Full Year 2020 Results
Brief: Exagen Partners With Boston's Tufts Medical Center
Brief: Exagen Inc Reports Preliminary Fourth Quarter 2020 Testing Results
Brief: Exagen Says Avise Test Offerings Are Contracted In-Network Service With St. Charles Health System In Central Oregon
promotion deal with Janssen
Promotion Agreement Dated December 10, 2018
Brief: Exagen Inc Extended Its Collaboration Agreement With GlaxoSmithKline PLC
Brief: Exagen Files For Mixed Shelf Of Upto $150 Million - SEC Filing